✦ LIBER ✦

Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac

✍ Scribed by Sitar, D S; Owen, J A; MacDougall, B; Hunter, T; Mitenko, P A

Book ID: 109843673
Publisher: Nature Publishing Group
Year: 1985
Tongue: English
Weight: 523 KB
Volume: 38
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.1985.163

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of aging on the pharmacokinet

The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin

✍ E. Andros; D. Detmar-Hanna; S. Suteparuk; J. Gal; J. G. Gerber 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 309 KB

Influence of age on the pharmacokinetics

Influence of age on the pharmacokinetics and pharmacodynamics of perindopril

✍ Lees, Kennedy R; Green, Stephen T; Reid, John L 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 616 KB

Influence of aging on the pharmacokineti

Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium

✍ Gariepy, L P; Varin, F; Donati, F; Salib, Y; Bevan, D R 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 608 KB

Effects of Age and Gender on the Pharmac

Effects of Age and Gender on the Pharmacokinetics (PK) and CNS Pharmacodynamics (PD) of Diphenhydramine (DIP)

✍ Slattum, P.W.; Briggs, G.C.; Hawley, J.M.; Garnett, W.R.; Venitz, J. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Age and the pharmacokinetics and pharmac

Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment

✍ Lees, Kennedy R; Reid, John L 📂 Article 📅 1987 🏛 Nature Publishing Group 🌐 English ⚖ 428 KB

Effects of renal function on recainam ph

Effects of renal function on recainam pharmacokinetics and pharmacodynamics*

✍ Cheng, Judy W. M.; Charland, Scott L.; Goldfarb, Stanley; Spinler, Sarah A. 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 671 KB

## Effects of renal function on recainam pharmacokinetics and pharmacodynamics Object&es: To investigate the pharmacokinetics and pharmacodynamics of recainam, an investigational class I antiarrhythmic agent, in subjects with various degrees of renal function. Methods: This single-dose open-label